Reporting Manager
Trails Edge Capital Partners, LP
Symbol
IMA
Shares outstanding
11,883,556 shares
Disclosed Ownership
1,176,472 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
21 Apr 2026, 16:30:19 UTC
Date of event
14 Apr 2026

Quoteable Key Fact

"Trails Edge Capital Partners, LP disclosed 9.9% ownership in ImageneBio, Inc. Common Stock, $0.001 par value per share (IMA) on 14 Apr 2026."

Quick Takeaways

  • Trails Edge Capital Partners, LP filed SCHEDULE 13G for ImageneBio, Inc. Common Stock, $0.001 par value per share (IMA).
  • Disclosed ownership: 9.9%.
  • Date of event: 14 Apr 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 21 Apr 2026, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 9.9% 1,176,472 1,176,472 0 /s/ Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 9.9% 1,176,472 1,176,472 0 /s/ Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 9.9% 1,176,472 1,176,472 0 /s/ Ortav Yehudai Ortav Yehudai / Individual
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .